Delving into the Latest Updates on Kehui Zhiyao Biotechnology (Shenzhen) Co., Ltd. with Synapse

Overview

Tags

Immune System Diseases

Nervous System Diseases

Neoplasms

Small molecule drug

AAV based gene therapy

Biological products

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	6
Nervous System Diseases	6
Neoplasms	4
Endocrinology and Metabolic Disease	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	9
AAV based gene therapy	2
Biological products	1
Proteolysis-targeting chimeras (PROTAC)	1

Top 5 Target	Count

IRAK1 x IRAK4	2
GBA1(Beta-glucocerebrosidase)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

11

1

Preclinical

Phase 1 Clinical

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

ARD-885 ( IRAK1 x IRAK4 )	Rheumatoid Arthritis More	Phase 1
Sunrise(Artivila)	Neurodegenerative Diseases More	Preclinical
GT(Artivila)	Neurodegenerative Diseases More	Discovery
Jet(Artivila)	Autoimmune Diseases More	Discovery
Lift(Artivila)	Neurodegenerative Diseases More	Discovery